DK0529033T3 - Nukleotidsekvenser, der koder for variable regioner af a-kæder i humane lumfocytreceptorer samt anvendelser heraf - Google Patents

Nukleotidsekvenser, der koder for variable regioner af a-kæder i humane lumfocytreceptorer samt anvendelser heraf

Info

Publication number
DK0529033T3
DK0529033T3 DK92905817T DK92905817T DK0529033T3 DK 0529033 T3 DK0529033 T3 DK 0529033T3 DK 92905817 T DK92905817 T DK 92905817T DK 92905817 T DK92905817 T DK 92905817T DK 0529033 T3 DK0529033 T3 DK 0529033T3
Authority
DK
Denmark
Prior art keywords
sequences
variable regions
nucleotide sequences
chains
applications
Prior art date
Application number
DK92905817T
Other languages
Danish (da)
English (en)
Inventor
Frederic Triebel
Sergio Roman-Roman
Laurent Ferradini
Thierry Hercend
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9101487A external-priority patent/FR2672616B1/fr
Priority claimed from FR9104527A external-priority patent/FR2675156B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0529033T3 publication Critical patent/DK0529033T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK92905817T 1991-02-08 1992-02-07 Nukleotidsekvenser, der koder for variable regioner af a-kæder i humane lumfocytreceptorer samt anvendelser heraf DK0529033T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9101487A FR2672616B1 (fr) 1991-02-08 1991-02-08 Sequences nucleotidiques codant pour des regions variables de chaines alpha des recepteurs de lymphocytes t humains, segments peptidiques correspondants et les applications diagnostiques et therapeutiques.
FR9104527A FR2675156B1 (fr) 1991-04-12 1991-04-12 Sequences nucleotidiques codant pour des regions variables de chaines alpha des recepteurs des lymphocytes t humains, segments peptidiques correspondants et les applications diagnostiques et therapeutiques.

Publications (1)

Publication Number Publication Date
DK0529033T3 true DK0529033T3 (da) 2007-01-08

Family

ID=26228502

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92905817T DK0529033T3 (da) 1991-02-08 1992-02-07 Nukleotidsekvenser, der koder for variable regioner af a-kæder i humane lumfocytreceptorer samt anvendelser heraf

Country Status (12)

Country Link
US (3) US5817511A (de)
EP (2) EP1721978B1 (de)
JP (1) JPH05509234A (de)
KR (1) KR100242278B1 (de)
AT (2) ATE504650T1 (de)
AU (1) AU660660B2 (de)
CA (1) CA2079879C (de)
DE (2) DE69233804D1 (de)
DK (1) DK0529033T3 (de)
ES (1) ES2271940T3 (de)
IE (1) IE920413A1 (de)
WO (1) WO1992013949A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072356A1 (en) * 1989-12-29 1991-06-30 James L. Urban Diagnosis and treatment of diseases
US7294712B2 (en) * 1990-06-04 2007-11-13 Aventis Pharma S.A. Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
JPH05509234A (ja) * 1991-02-08 1993-12-22 ルセル　ユクラフ ヒトＴリンパ球レセプターのα鎖の可変領域をコードするヌクレオチド配列対応するペプチドセグメント並びに診断及び治療への利用
IE920447A1 (en) * 1991-02-12 1992-08-12 Roussel Uclaf NUCLEOTIDE SEQUENCES CODING FOR ß-CHAIN VARIABLE REGIONS OF¹HUMAN T-LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDE SEGMENTS¹AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
DE4225569C2 (de) * 1992-08-03 1996-04-25 Max Planck Gesellschaft Verwendung einer Sonde zur Tumordiagnostik oder Tumortherapie
JP3875730B2 (ja) * 1993-02-22 2007-01-31 サノフィ・アベンティス株式会社 自己免疫疾患の予防治療剤
CA2188182A1 (en) * 1994-04-18 1995-10-26 Steven M. Friedman Conserved t-cell receptor sequences
EP1095948A1 (de) * 1999-10-28 2001-05-02 Universitätsklinikum Freiburg Idiotype Impstoffe
KR100363271B1 (ko) * 2000-06-12 2002-12-05 주식회사 동진쎄미켐 포토레지스트 리무버 조성물
US20060275747A1 (en) * 2001-12-07 2006-12-07 Hardy Stephen F Endogenous retrovirus up-regulated in prostate cancer
JP2005535308A (ja) 2002-06-13 2005-11-24 カイロン コーポレイション Ｈｍｌ−２ポリペプチド発現用ベクター
EP1517995A4 (de) * 2002-07-03 2007-07-11 Inst Scient Res Inc Zusammensetzungen und verfahren zum nachweis der expression von genen der variablen menschlichen t-zellrezeptor-familie
FR2863274B1 (fr) 2003-12-05 2012-11-16 Commissariat Energie Atomique Procede d'evaluation quantitative d'un rearrangement ou d'une recombinaison genetique ciblee d'un individu et ses applications.
EP2044949A1 (de) 2007-10-05 2009-04-08 Immutep Verwendung von rekombinantem LAG-3 oder Derivaten daraus zur Auslösung einer Monozyten-Immunreaktion
US8497071B2 (en) * 2009-06-29 2013-07-30 California Institute Of Technology Isolation of unknown rearranged T-cell receptors from single cells
GB201322626D0 (en) 2013-12-19 2014-02-05 Immutep S A Combined preparations for the treatment of cancer
JOP20200094A1 (ar) 2014-01-24 2017-06-16 Dana Farber Cancer Inst Inc جزيئات جسم مضاد لـ pd-1 واستخداماتها
CU24481B1 (es) 2014-03-14 2020-03-04 Immutep Sas Moléculas de anticuerpo que se unen a lag-3
US10202640B2 (en) * 2014-05-07 2019-02-12 The Board Of Trustees Of The Leland Stanford Junior University Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing
GB201500374D0 (en) 2015-01-09 2015-02-25 Immutep S A Combined preparations for the treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874845A (en) * 1984-06-13 1989-10-17 Massachusetts Institute Of Technology T lymphocyte receptor subunit
EP0200350A3 (de) * 1985-04-15 1987-05-13 The Ontario Cancer Institute Nukleinsäure mit Code für ein T-Zellen-Antigenrezeptor-Polypeptid
EP0616811A1 (de) * 1985-12-03 1994-09-28 T Cell Sciences, Inc. Zellfreier T-Zell-Antigenrezeptor und dessen klinische Verwendungen
US4892827A (en) * 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects
US5223426A (en) * 1988-12-15 1993-06-29 T Cell Sciences, Inc. Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor
US5216132A (en) * 1990-01-12 1993-06-01 Protein Design Labs, Inc. Soluble t-cell antigen receptor chimeric antigens
JPH05509234A (ja) * 1991-02-08 1993-12-22 ルセル　ユクラフ ヒトＴリンパ球レセプターのα鎖の可変領域をコードするヌクレオチド配列対応するペプチドセグメント並びに診断及び治療への利用

Also Published As

Publication number Publication date
AU660660B2 (en) 1995-07-06
US6114516A (en) 2000-09-05
AU1360392A (en) 1992-09-07
DE69233652D1 (de) 2006-10-12
DE69233652T2 (de) 2007-09-27
ATE504650T1 (de) 2011-04-15
WO1992013949A1 (fr) 1992-08-20
IE920413A1 (en) 1992-08-12
US5817511A (en) 1998-10-06
EP0529033B1 (de) 2006-08-30
US5798231A (en) 1998-08-25
CA2079879A1 (fr) 1992-08-09
EP0529033A1 (de) 1993-03-03
ES2271940T3 (es) 2007-04-16
ATE338134T1 (de) 2006-09-15
DE69233804D1 (de) 2011-05-19
KR100242278B1 (ko) 2000-02-01
CA2079879C (fr) 2007-11-06
EP1721978B1 (de) 2011-04-06
JPH05509234A (ja) 1993-12-22
EP1721978A1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
DK0529033T3 (da) Nukleotidsekvenser, der koder for variable regioner af a-kæder i humane lumfocytreceptorer samt anvendelser heraf
NL300008I1 (nl) Tumornecrosis factor-alfa en -beta-receptors.
Krangel et al. Structurally divergent human T cell receptor γ proteins encoded by distinct Cγ genes
BR9007197A (pt) Cadeia pesada,cadeia leve e molecula de anticorpo,sequencia de dna,vetor de clonagem,celula hospedeira,processos para produzir uma sequencia de anticorpo e um produto de anticorpo,composicao terapeutica e processo de terapia ou diagnose
Desplan et al. Sequence of rat intestinal vitamin D-dependent calcium-binding protein derived from a cDNA clone. Evolutionary implications.
CY1105687T1 (el) Οικογενεια ανοσορυθμιστων που οριζονται ως υποδοχεις λευκοκυτταρων παρομοιοι με ανοσοσφαιρινες (lir)
Hara et al. Primary structures of two types of alpha-subunit of rat brain Na+, K+-ATPase deduced from cDNA sequences
ATE205254T1 (de) Transformierender wachstumsfaktor alpha h1
FI883056A0 (fi) Nya former av kolonistimulerande faktor-1.
ES2120964T3 (es) Peptidos osteogenicos.
Suran et al. N-terminal sequences of heavy and light chains of leopard shark immunoglobulins: evolutionary implications.
O'donnell et al. A novel host-protective antigen from Trichostrongylus colubriformis
FI965043A0 (fi) Suuriaffiniteettisia melatoniinireseptoreita ja niiden käyttö
ATE283368T1 (de) Für die glutamatabhängigen chloridkanäle kodierende dna
AR010337A1 (es) Acido nucleico aislado, molecula de acido nucleico, sonda, vector de expresion recombinante, celula, metodo para producir un polipeptido de h.pylori, metodo para detectar la presencia de un acido nucleico helicobacter, polipeptido de h.pylori aislado, proteina de fusion, formulacion para vacuna
ATE230026T1 (de) Menschliches wachstumsgen und minderwuchse gen bereich
Fellah et al. Structure and diversity of the T-cell receptor α chain in the Mexican axolotl
DE59109085D1 (de) Epididymis-spezifische Polypeptide und deren Verwendung
Kino et al. A novel chain of basement membrane-associated collagen as revealed by biochemical and immunohistochemical characterizations of the epitope recognized by a monoclonal antibody against human placenta basement membrane collagen.
ATE229983T1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
DK43991D0 (da) Allele varianter af plasmodium falciparum merozoitoverfladeantigen